Corona Virus Increased Respiratory Disease Testing Market
Covid-19, which is known as Corona virus is spreading all over the world. A man who is suffering from common cold, wants to test and be confirmed, whether he is suffering from Corona Virus or not?
This is increasing demand of testing kits like PPR The global respiratory disease testing market is witnessing a surge in market for Corona Virus test kit. This is creating extra demand in health care market.
The rising frequency of respiratory diseases, triggered by the rapid increase in the global geriatric population, has given an impetus to the market in the past.
Fighting with Corona Virus
CDC has developed a new laboratory test kit for use in testing patient specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.
The test kit is called the “Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel.”
This trend is also expected to boost the worldwide market for respiratory disease testing during the period from 2014 to 2022 significantly.
The respiratory system plays a key role in the delivery of oxygen to the body and also removes carbon dioxide waste from the body. In addition.
The system also eliminates toxic waste, stabilizes blood-alkaline balance (pH), and regulates temperature.
Respiratory diseases like corona virus, inhibit this normal functioning of the respiratory system and may occur as a result of causes death. Because it attacks Lungs such as the inhalation problem.
As per the report, the rising aging population raises the utilization of respiratory disease testing products, thus having a positive impact on the growth of the market.
In addition, the increasing occurrence of respiratory diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis which is the cause of corona virus,. is the reason of increasing test.
Also propels the growth of the market for respiratory disease testing. Furthermore, the rising technological developments will also have a positive impact on the development of this market.
On the other hand, the report states that the decreasing adoption of advanced spirometers, PPR and digital radiography systems is a key factor impeding the growth of the market.
Avail a Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288
In terms of test, the respiratory disease testing market is segmented into spirometry tests, imaging tests, blood gas tests, peak flow tests, lung volume tests, and other tests. Amongst these, the segment of imaging tests led the market in 2013.
The reason for the dominance of this segment is the increasing demand for imaging tests such as X-rays, etc. Additionally, imaging tests have also emerged as the first-line diagnostic tests for a number of respiratory diseases.
By end use, the respiratory disease testing like corona virus, market is segmented into physician offices, clinical laboratories, and hospitals.
Amongst these, hospitals constituted the largest share in the market for respiratory disease testing in 2013. The reason for the dominance of this segment is the wide-ranging use of respiratory diagnostic instruments.
On the basis of geography, the report segments the market into North America, Europe, Asia Pacific, and Rest of the World (RoW). Amongst these, North America constituted the largest share in the market in 2013.
This is owing to the rising occurrence of respiratory diseases and the increasing demand for home healthcare services and devices here.
On the other hand, the Asia Pacific respiratory disease testing market is predicted to rise at the swiftest growth rate in the coming years.
As per the report, the chief players operating in the market are COSMED, CareFusion Corp., Carestream Health Inc., Futuremed America Inc., GE Healthcare, NIHON KOHDEN Corp., Perkin Elmer Inc., Philips Healthcare, SDI Diagnostics, Smiths Medical, and Siemens Healthcare, among others.
Key segments of the Respiratory Disease Testing Market
By End User